Home > Press > FAU researchers develop nanoparticles for biomedical applications
 |
| Image: Panthermedia/Andriy Popov |
Abstract:
An international, interdisciplinary team of researchers is developing highly porous biomaterials for localised release of therapeutic ions and drugs in the MOZART project which has received 4.65 million euros in funding. Materials scientist Prof. Dr. Aldo R. Boccaccini is head of the team of researchers at Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), one of the project’s academic partners. MOZART is being funded by Horizon 2020, the EU Framework Programme for Research and Innovation.
FAU researchers develop nanoparticles for biomedical applications
Erlangen, Germany | Posted on January 19th, 2016The body’s powers of regeneration sometimes fail. Around 350,000 people a year suffer from broken bones that cannot heal by themselves, while around 2.2 million patients with conditions such as diabetes have to cope with chronic open wounds. MOZART (Mesoporous matrices for localized pH-triggered release of therapeutic ions and drugs) aims to help these patients. The goal of the project is to use mesoporous – i.e. highly porous – silicate nanomaterials to support bone and wound healing.
The team of FAU researchers led by Prof. Dr. Aldo R. Boccaccini, Chair of Biomaterials, are developing new inorganic and mesoporous materials whose pores are approximately ten nanometres in size and which have a unique chemical composition. ‘The pores of these bioactive particles will be enriched with active agents and are designed to release medication locally in a controlled manner, meaning that the active agent is released in the location where it is required,’ Prof. Boccaccini explains. ‘This allows doses to be reduced and side affects to be avoided.’
The overall goal of the four-year project is to develop a database of new and bioactive nanomatrices. ‘We are delighted that we are able to contribute our expertise to such an important project,’ Prof. Boccaccini says. ‘If our new and innovative developments can be used in clinical application, this will benefit patients and enrich Europe’s healthcare sector.’
The MOZART consortium consists of five high-tech SMEs and six European universities, including FAU, the Polytechnic University of Turin, Complutense University of Madrid and the University of Sheffield. The European Commission is funding the project with a total of 4.65 million euros. As an academic partner, FAU’s Institute for Biomaterials has been allocated around 382,000 euros of this funding.
####
For more information, please click here
Contacts:
Prof. Dr Aldo R. Boccaccini
Phone: +49 9131 8528601
Copyright © Friedrich-Alexander-Universität
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Bookmark:
| Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Govt.-Legislation/Regulation/Funding/Policy
New discovery aims to improve the design of microelectronic devices September 13th, 2024
Physicists unlock the secret of elusive quantum negative entanglement entropy using simple classical hardware August 16th, 2024
Single atoms show their true color July 5th, 2024
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Discoveries
Breaking carbon–hydrogen bonds to make complex molecules November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Materials/Metamaterials/Magnetoresistance
Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024
Focused ion beam technology: A single tool for a wide range of applications January 12th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Nanobiotechnology
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024
Research partnerships
Gene therapy relieves back pain, repairs damaged disc in mice: Study suggests nanocarriers loaded with DNA could replace opioids May 17th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
Researchers’ approach may protect quantum computers from attacks March 8th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||